These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35653344)

  • 41. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma.
    Wu S; Lv X; Wei H; Wu J; Liu S; Li X; Song J; Zou C; Ai Y
    J Cell Mol Med; 2024 Mar; 28(5):e18083. PubMed ID: 38393307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.
    Shen Y; Wei Z; Zhou C; Song J; Wang J; Wang J; Wu L; Fang S; Shen Z
    J Clin Lab Anal; 2022 Sep; 36(9):e24600. PubMed ID: 35870182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma.
    Liu S; Wang S; Wang Z
    BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
    Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
    Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
    Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
    Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
    Liu S; Wang Z
    Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
    Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.
    Liu J; Wu Y; Wang Q; Liu X; Liao X; Pan J
    Future Oncol; 2018 Feb; 14(5):449-459. PubMed ID: 29322815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.
    Knebel M; Körner S; Kühn JP; Wemmert S; Brust L; Smola S; Wagner M; Bohle RM; Morris LGT; Pandey A; Schick B; Linxweiler M
    Front Immunol; 2023; 14():1172768. PubMed ID: 37383237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
    Xiao T; Lin F; Zhou J; Tang Z
    Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of senescence-related tumor microenvironment genes in head and neck squamous cell carcinoma.
    Lee YC; Nam Y; Kim M; Kim SI; Lee JW; Eun YG; Kim D
    Aging (Albany NY); 2023 Dec; 16(2):985-1001. PubMed ID: 38154113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
    Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
    Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
    Lu D; Mihoayi M; Ablikim Y; Arikin A
    Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma.
    Hu Z; Zhou J; Li Y; Luan Y; Li H; Jia B; Xie Z; Cheng B; Wu T
    Front Immunol; 2022; 13():915207. PubMed ID: 36148222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subclass-Specific Prognosis and Treatment Efficacy Inference in Head and Neck Squamous Carcinoma.
    Zheng Z; Xie W; Chen X; Wang F; Huang L; Li X; Lin Q; Wong KC
    IEEE J Biomed Health Inform; 2022 Aug; 26(8):4303-4313. PubMed ID: 35439152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
    Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
    J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.